Stories from Surgical Aesthetics
Thursday, September 14, 2017 - 12:35
Before-and-after images are one of the most effective patient satisfaction and marketing tools available to aesthetic practices. But the quality of your photos is key to reaping the benefits. Different backgrounds, varying hairstyles, and changes in patient positioning may raise red flags for savvy patients, while poor lighting can detract from the outcomes you are trying to highlight.
Thursday, September 14, 2017 - 12:32
Allergan has updated it Brilliant Distinctions patient reward program with new digital tools and new qualifying services. Patients can now earn rewards for CoolSculpting treatments in addition to Botox Cosmetic and Juvederm procedures, Skinmedica products and Latisse purchases. They can also purchase Skinmedica products online through the new Brilliant Connection e-commerce site.
Thursday, September 14, 2017 - 12:29
Breast implant manufacturers Allergan and Sientra have each made financial contributions to the American Society for Aesthetic Plastic Surgery (ASAPS) to help fund the development of software that will enable ASAPS to acquire data on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The technology will enable both the organization and the industry to garner data and improve outcomes directly at the point-of-care, via ASAPS member practices.
Thursday, September 14, 2017 - 12:18
George J. Hruza, MD, immerses himself in the dermatology community to ensure a stronger specialty and take advantage of lifelong learning opportunities.By Keith LoriaGeorge J. Hruza, MD, has always been surrounded by the medical field. His mother was a pediatrician, who later became a psychiatrist. His father was a gerontology researcher and pathologist. His sister is a radiologist; her husband is a rheumatologist. So it’s no surprise that Dr. Hruza, founder of the Laser & Dermatologic Surgery Center in Chesterfield, Missouri, also sought a career in medicine. “It seemed like a profession...
Thursday, September 7, 2017 - 11:56
In a statement released on August 28, 2017, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, outlined the agency’s new policy goals and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine. His statement reads in part:
Thursday, September 7, 2017 - 11:53
Alisa Lask is the new vice president and general manager of Galderma’s Aesthetic & Corrective Business unit in the U.S. Chris Chapman has been named vice president and general manager of the company’s Prescription Business unit in the U.S.
Thursday, September 7, 2017 - 11:46
Aesthetic practitioners offering minimally invasive injectable treatments for rejuvenation of the lower third of the face should start with soft-tissue fillers to provide structure and support before considering botulinum toxins to reduce fine lines, according to an article by Mauricio de Maio, MD, et al, published in Plastic and Reconstructive Surgery (September 2017). Treatment recommendations offered by the authors of “Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face” include:
Thursday, September 7, 2017 - 11:44
Microdroplet injections of low-viscosity hyaluronic acid-based fillers are gaining fans around the globe.By Inga HansenHydrating fillers—low-viscosity hyaluronic acid-based materials injected superficially throughout the face to improve skin tone—have become popular offerings outside of the U.S. and are finding their way onto aesthetic message boards and review sites, generating significant interest among U.S.-based consumers. Outside the states, physicians have access to specifically formulated products, such as Juvéderm Hydrate, Restylane Vital and Restylane Vital Light, as well as robust...
Monday, August 28, 2017 - 12:04
FEATURES The most buzzworthy new antiaging actives »Cutting-Edge Ingredients
Thursday, August 24, 2017 - 09:47
A closer look at some of the most buzzworthy new ingredients in antiaging skin care.By Inga HansenNew products that promise to “unlock a more youthful appearance,” “turn back the hands of time,” and “reset the aging process” bombard consumers and skincare professionals on a seemingly daily basis. While we know that topical skincare is vital to skin health, the question is, do these new ingredients deserve a space on your retail shelves?
Thursday, August 24, 2017 - 09:36
Patients with cellulite and skin laxity who underwent treatment with microfocused ultrasound with visualization (MFU-V; Ultherapy) in combination with diluted calcium hydroxylapatite (CaHa; Radiesse) saw a significant improvement in laxity and a significant reduction in dimpling. Gabriel Casabona, MD, and Gregorio Pereira, MD, published the results of their retrospective study of 20 female patients (mean age: 40.0 ± 8.2 years; mean BMI 21.5 ± 1.5 kg/m2) in Plastic and Reconstructive Surgery – Global Open (July 2017).
Thursday, August 24, 2017 - 09:33
Revance Therapeutics, a biotechnology company developing botulinum toxin products for aesthetic and therapeutic concerns has appointed Todd Zavodnick to chief commercial officer and president of its Aesthetics & Therapeutics division. Zavodnick will report to Revance’s CEO Dan Browne, and lead the company’s commercial operations along with the launch of its injectable daxibotulinumtoxinA (RT002).
Thursday, August 24, 2017 - 09:29
In an effort to help patient’s understand the relative risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), authors of a study published in the September 2017 issue of Aesthetic Surgery performed a micromort analysis, which measures relative risk of activities and exposures.
Thursday, August 17, 2017 - 14:14
A mouse study from the O’Donnell Brain Institute and University of California, Irvine, showed that eating at abnormal times disrupts the circadian rhythm of the skin and alters the potency of an enzyme that protects it against ultraviolet radiation.
Thursday, August 17, 2017 - 14:12
A review study published in the September 2017 issue of the Journal of the American Academy of Dermatology supports the role of Demodex mites in rosacea. Ying Shuo-Chang, MD, and Yu-Chen Huang, MD, of Taipei Medical University Hospital, Taiwan, performed a literature search in PubMed, MEDLINE, and EmBase databases from inception through October 31, 2016. They searched the terms “Demodex” and “Demodex Mites” combined with “Rosacea.” All studies included in their review and meta-analysis were human clinical trials published in English.
Thursday, August 17, 2017 - 14:10
Aesthetic laser and light system manufacturer Sciton is celebrating is celebrating its 20-year anniversary this year with a limited-time website and a two-day User Summit scheduled for November 11-12, 2017. The new Sciton website offers a brief history of the company’s product development, physician testimonials, and profiles of long-term employees.
Thursday, August 17, 2017 - 14:08
An experimental device that offers multiple tunable wavelengths—the TRASER (Total Reflection Amplification of Spontaneous Emission Radiation)—is safe and effective in the treatment of nasal telangiectasias, according to a study published in Lasers in Surgery and Medicine (August 2017).
Thursday, August 10, 2017 - 11:49
Larry Brilliant, MD, MPH, will deliver the opening keynote address at the 2017 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) on October 5 in Chicago.